Ripretinib: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ripretinib. Educational only — not medical advice.
Labeled uses
QINLOCK is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
Source: FDA labeling via NIH DailyMed (set 9f18e462…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.